• Non ci sono risultati.

Geographic variation in inpatient costs for Acute Myocardial Infarction care: Insights from Italy

N/A
N/A
Protected

Academic year: 2021

Condividi "Geographic variation in inpatient costs for Acute Myocardial Infarction care: Insights from Italy"

Copied!
8
0
0

Testo completo

(1)

ContentslistsavailableatScienceDirect

Health

Policy

jo u rn al h om ep a g e :w w w . e l s e v i e r . c o m / l o c a t e / h e a l t h p o l

Geographic

variation

in

inpatient

costs

for

Acute

Myocardial

Infarction

care:

Insights

from

Italy

Chiara

Seghieri

a,

,

Paolo

Berta

b

,

Sabina

Nuti

a

aInstituteofManagementandDepartmentEMbeDS,ScuolaSuperioreSant’Anna,PiazzaMartiridellaLibertà33,56127Pisa,Italy bDepartmentofQuantitativeMethods,UniversityofMilanoBicoccaViaBicoccadegliArcimboldi8,20126Milano,Italy

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received24December2017

Receivedinrevisedform18January2019 Accepted19January2019

Keywords: Geographicvariation Healthcareexpenditures Acutemyocardialinfarction Governancemodels Recycleprediction

a

b

s

t

r

a

c

t

Geographicvariationsinhealthcareexpenditureshavebeenwidelyreportedwithinandbetween

coun-tries.Nevertheless,empiricalevidenceontheroleoforganizationalfactorsandcaresystemsinexplaining

thesevariationsisstillneeded.Thispaperaimsatassessingtheregionaldifferencesinhospitalspending

forpatientshospitalizedforAcuteMyocardialInfarction(AMI)inTuscanyandLombardyregions(Italy),

whichrankhighintermsofcarequalityandthathavebeen,atleastuntil2016,characterizedbyquite

differentgovernancesystems.Generalizedlinearmodelsareperformedtoestimateindex,30-dayand

one-yearhospitalizationspendingadjustedforbaselinecovariates.Atwo-partmodelisusedto

esti-mate31–365dayexpenditure.AdjustedhospitalspendingforAMIpatientsweresignificantlyhigher

inLombardycomparedwithTuscany.InLombardy,patientsexperiencedhigherre-hospitalizationsin

the31–365daysandlongerlengthofstaysthaninTuscany.Ontheotherhand,nosignificantregional

differencesinadjustedmortalityratesatbothacuteandlongerphaseswerefound.

Comparingtworegionalhealthcaresystemswhichmainlydifferinboththereimbursementsystems

andthelevelofintegrationbetweenhospitalandcommunityservicesprovidesinsightsintofactors

potentiallycontributingtoregionalvariationsinspendingand,therefore,inareasforefficiency

improve-ment.

©2019TheAuthor(s).PublishedbyElsevierB.V.ThisisanopenaccessarticleundertheCC

BY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/4.0/).

1. Introduction

Thegeographicvariationinhealthcareacrossandwithin

coun-triesiswelldocumented,andatalllevelssuchasbetweendifferent

healthcareservicesandbetweenbothlargeandsmallareas[1,2].

Partofthisgeographicvariationisexpectedandoftenlinkedto

dif-ferencesinpopulationhealthandneeds(suchdemographicsand

healthstatus).However,someofthisvariationmaybeunwarranted

anddrivenbynon-clinicalfactors,suchasprofessionaldecision

making,theavailability anddistributionof resources,physician

incentives,financingandreimbursementmodels[2].Themain

pol-icychallengeisthusnottoeliminatevariationaltogetherbutto

identifyareasof variationwhere populationcharacteristicsand

healthoutcomesarecomparablebuthigher-than-averagecosts

suggestthepotentialforimprovedefficiency.Evidencefromthe

Dartmouthresearchgroupsuggestedthatevenafteradjustingfor

differencesinpopulationcharacteristicsandinpricelevels,

high-treatmentintensity regions weregenerally not associated with

∗Correspondingauthor.

E-mailaddress:c.seghieri@santannapisa.it(C.Seghieri).

betteroutcomesbutwithsignificantlyhigherspending.Theresults

showedthatifalltheseregionshadreducedcarevolumestothe

levelobservedinlow-spendingregionswithasimilarlevelofcare

quality, approximately30%in spendingcouldhave beensaved.

Higherefficiencycouldthusbeachievedbyidentifyingand

reduc-ingunwarrantedvariationwithoutproducingworseoutcomes,on

average,orreductionsinthequalityofcare[3–6].

Despitesimilarvariationswerecorroboratedbyalargebody

of literature in US [7,8] and more recently in other advanced

economies[9–13],thereisstilllittleagreementaboutthecauses

andtheclinicalimplicationsofthesereportedvariations.

Numer-ous possiblefactorsof varyingimpactcoulddrivevariationsin

spending,themajorityofthestudiesfoundthatthehighest

per-centage ofvariationsisduetosupply-sidefactorsincludingthe

typesofservicesprovided[8],paymentdifferentials[14]physician

behavior[15].However,otherstudiesshownthatcostvariations

werenotduetosystemicinefficienciesbutmostlytopopulation

healthstatus[16,17].

Additionally,mostfindingsinUSconfirmedthatgreaterhealth

carespendingdoesnotnecessarilycorrelatewithbettercareor

betterhealth[8,18–20].However,indistinctiontotheDartmouth

https://doi.org/10.1016/j.healthpol.2019.01.010

0168-8510/©2019TheAuthor(s).PublishedbyElsevierB.V.ThisisanopenaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/ 4.0/).

(2)

research,otherstudiesinUSshowedthatmorespendingand

uti-lizationarelikelytoleadtobetteroutcomes[21–25].

Otherrecent studies in Europealso reported mixed results.

Whilesomeresearcheshaveshownthatwithincountryvariations

inhealthexpendituresaremainlyexplainedbymedicalneed[26]

andthatexpendituresarelikelytobepositivelyrelatedtohealth

outcomes[27],otherstudies,althoughconfirmingsignificant

vari-ationsincostsandoutcomesacrossandwithincountriesandfor

differentconditions,didnotfoundanyclearcost-qualitytradeoff

pattern[28,29,13,30].

Regardless the magnitude and direction of the association

betweenhealthcarecostsandoutcomes,itseemsthatthereisa

largeproportionofvariationinspendingandutilizationamongand

withincountrieswhichmightreflectdifferencesininefficiencies.

Furtherresearchisthereforeneededtogainabetterunderstanding

oftheunderlyingdriversofvariationsandtoidentifytherelated

healthpolicyimplications.

Inthis context,thepresent studyaimsat analysingregional

variationinhospitalspendingforpatientswithAcuteMyocardial

Infarction(AMI) inItaly. Using specific econometricmodelsfor

healthcarecosts,wecompareone-yeartreatmentsand

Diagnostic-RelatedGroup(DRG)-basedexpendituresofpatientshospitalized

forAMIinLombardyandTuscanyregionswhichareboth

character-izedbysimilarhigh-performinghealthcaresystemsbut,however

differ in terms of institutional settings. In particular, Tuscany

healthcaresystemisbasedonastrongintegrationbetweenthe

var-ioushealthcareproviderstofavourtheefficientuseofbothacute

andpost-acuteservices,andonplanning,targetsettingand

com-petitivebenchmarkingonqualityofcarethatplayacrucialrolein

theregionalgovernance.Lombardyhasadopteduntil2016a

quasi-marketsystemmadeupofbothpublicandprivateprovidersand

basedonaprospectivepaymentsystemtoreimburse

hospitaliza-tions[31–34].ThedistinctdifferencesbetweenLombardy’squasi

marketgovernancemodelandtheintegratedcaremodelof

Tus-canyofferavaluableopportunitytoexploreregionalvariationsin

healthcarespending.

WefocusoncomparisonofAMIcareforseveralreasons

sup-portedbythescientificliterature[35,36],includingthefactthat

AMIis one of the most commonhospital admission; that it is

anacuteconditionwhichisnotrelatedtothepatients’choiceof

providers,patientsareinfactgenerallytakentothenearesthospital

forimmediatetreatment,and,althoughthereisagrowing

interna-tionalconsensusonwhichtreatmentsshouldbeadministeredto

AMIpatients,geographicvariationsinqualityandtreatment

inten-sityarewidelydocumented[13].Moreover,thehospitalizationfor

AMIisawell-definedindexevent,whichislikelytobesimilarly

definedacrossandwithincountries.

2. ThehealthcaresystemsofLombardyandTuscany

Regions

The Italian National Healthcare System (NHS) follows the

Beveridge model [37], providing universal healthcare coverage

throughouttheItalianStateasasinglepayer.Itentitlesallcitizens,

regardlessoftheirsocialstatus,toequalaccesstoessential

health-careservices.In1992,asystemreformtransferredadministrative

andorganizationalresponsibilitiesandtasksfromthecentral

gov-ernmenttotheadministrationsofthe21regionsinItaly.These

regionsnowhavesignificantautonomyontherevenuesideand

inorganizingservicesdesignedtomeettheneedsoftheir

respec-tivepopulations[38,34].Acrossyears,thedecentralizedstructure

oftheItalianNHShasledtotheemergenceofarangeof

differ-entgovernancemodelsattheregionallevel[33],whichofferrich

opportunitiesforcomparativestudyoftheimpactofdifferent

insti-Table1

DescriptionoftheTuscanyandLombardyhealthcaresystems.

TuscanyRegion LombardyRegion

No.Inhabitants(million) 3,7 10

Populationdensity(inh./km2) 163.24 419,11

Lifeexpectancy(years) 85 85

No.ofpublichospitals 40 98

No.ofprivatehospitals 0 102

tutionalsettingsoncostsandoutcomes(i.e.onthevaluecreation

process[39]).

Amongthe20Italianregions,bothLombardyandTuscanyare

amongwealthiestregionsinItalyandtheirpopulationaresimilar

intermsofhealthconditionsandlifestyles.AsshowninTable1,

Tuscanycountsabout3,7inhabitantswhileLombardyabout10

mil-lions.Lifeexpectancyatbirthisof85yearsinbothregionsandthe

percentageofpeoplereportingofbeingingoodhealthconditions

are71.5%and71.2%inTuscanyandLombardyrespectively(Source:

http://dati.istat.it).Thetworegionsarebothcharacterizedbyhigh

qualityhealthcaresystems[40,41]butwithdifferentapproachesto

theorganisationofhealthcaredeliveryandtothefinancingmodel.

TheLombardyhealthcaresystemcomprisesapproximately200

hospitalsgenerating2milliondischargesannually;18billionEuros

aredevotedtohealthcareexpenditures(80%oftheregionalbudget)

everyyear.Theregionalhealthcaresystemwasreformedin1997

becomingaquasi-marketcharacterizedbyaseparationbetween

healthcarepurchasersandproviders,andwhereprivateproviders

deliverthe30%ofthehospitalizationsperyearandcompetewith

thepublicproviders.Patients,therefore,arefreetochoosewhere

to behospitalized whether in any privateor public accredited

providersAnessi-Pessinaetal.[31,33,42,43].

DifferentlyfromLombardy,thehealthcaresysteminTuscany

isbasedona strongintegrationbetweenthevarioushealthcare

providerstofavourtheefficientuseofbothacuteandpost-acute

services.Planning,targetsettingandcompetitivebenchmarking

playcrucialrolesintheregionalgovernance[40]ofTuscany.The

systemcomprisesabout40publicprovidersand34healthdistricts

that areincharge oforganize anddeliverservicesof territorial

healthnetworks,socialcareandsocialintegration.Startingfrom

2016,theRegionalHealthcareSystemhasbeenreformedby

aggre-gatingtheexisting12LocalHealthAuthorities(LHAs)intothree

majornewLocalHealthAuthoritieswhilekeepingtheexistingfour

TeachingHospitals.Morethan95%ofhospitalbedsarepublicand

eachoftheLHAsarefinancedbytheregionaladministrationunder

aglobalbudgetwithaweightedcapitationsystem,thatis,funds

areallocatedtoprovidersthroughanadministrativeprocessnot

directlylinkedtopatientvolumes.Ontheotherhand,budgetcost

controlandqualitycaretargetsareappliedtoteachinghospitals.

Eventhoughpatientshaveafreechoiceofhealthcareprovider,the

absenceofaclearlinkbetweenvolumesandreimbursementmeans

thathospitalsdonothavethesameincentivetocompeteformarket

sharethattheydoinDRG-basedfinancingsystems.Indeed,

hospi-talsinTuscany,aremorefocusedonoutcomeandappropriateness

targetsthataremonitoredthroughabenchmarkingapproachand

throughpublicdisclosureofproviders’performancelevels(http://

performance.sssup.it/netval).

WithregardtotheorganizationofcareforAMI,inItalythere

hasbeenarisinginAMIcarenetworkcoverageacrossthewhole

territory,withagrowingnumberofPercutaneousCoronary

Inter-vention (PCI)promptlydelivered [44]. Thisholds also for both

TuscanyandLombardyregions,inwhichrevascularizationservices

arepromptlyaccessedbytheregionalpopulationsexceptforfew

municipalitieswhicharemorethan60mindistantfromthe

near-estcarenetwork[44].Moreover,inthelastyears,thehealthcare

(3)

inte-gratednetworkofcardiachealthservices,followingthelogicof

Hub&Spokemodel[45],whereasaccesstotreatmentofAMIin

Lombardyisassuredthroughthecoordinationamonghospitalsand

emergencyservices,especiallyforthetreatmentofSTEMIpatients

[46,47].

3. Methods

3.1. Datasources

Weconductedaretrospectivecohortstudyusingdatafrom

hos-pitaldischargerecordsfromTuscanyandLombardy.Theanalysis

includedallpatientsdischargedwithaprimarydiagnosisofAMI

(InternationalClassificationofDeceases,9threvision,Clinical

Mod-ification-ICD-9-CMcodes:410.xx)betweenJanuary1,2012,and

December31,2013,fromallhospitalsinTuscanyandLombardy.

Admissionslastinglessthantwodayswereexcluded,aswell

ashospitalizationsofpatientsnotresidentinthetworegions.The

analysisconcernedpatientsolderthan18yearsandyoungerthan

100years.Recordswithadiagnosticcode410.9AMIofunspecified

site,andadiagnosticcode410.×2subsequentepisodeofcarefor

dischargedpatientswerealsoexcludedfromtheanalysis.

IfapatienthadmorethanoneadmissionforAMIduringany

studyyear,werandomlyselectedoneofthoseadmissionsforeach

studyyear[48,49]. StartingwiththeAMIhospitalization (index

admission),eachpatientwasthenfollowedforoneyeartomeasure

variationsinhospitalizationvolumesandspendingacrossTuscany

andLombardy,bothattheinitialAMIepisodeandduringthe

post-hospitalizationperiod.

The study observationwas divided into fourperiods: index

admission(1), allhospitalizationsupto30daysfromtheindex

admission(0–30)(2),fromdays31to365(3),andoverall1-year

hospitalizations(4).The0–30dayswindowcanbeconsideredas

theacutephaseofAMImanagementwhenpatientsshouldreceive

mostoftheguideline-basedadmissiontherapies(i.e.acute

reperfu-siontherapy),andre-hospitalizationsinthisperiodmaybestrongly

linkedtotheadmissionepisodeof care.Ontheotherhand,

re-hospitalizationoncetheacutephasehaspassed(i.e.fromday31

to365)shouldalsodependontheprimarycareandcommunity

supportprovidedtopatients.

Foreachpatient,hospitalizationcostsatindexandpost-index

periodswereidentifiedusingtheDRGreimbursementregistered

intheHDRs.Inordertotakeintoaccountoftheinter-regional

differencesinspendingassociatedwithdifferencesinDRGtariffs,

expenditureswerecalculatedfortheAMIpatientsofeachregion

byapplyingtheLombardyDRGtariffsystemtothe

correspond-ingDRGsinTuscany.Data hadalreadybeenanonymizedatthe

RegionalHealthInformationSystemOffice,whereeachpatientwas

assignedauniqueidentifier.Thisidentifierpreventsthepatient’s

identityandothersensitivedatafrombeingtraced.Thestudywas

carriedoutincompliancewithItalianlawonprivacy,andapproval

byanEthicsCommitteewasnotrequired.

3.2. Methodologicalapproach

The major methodological issues that arise when analysing

healthcarecostsarethatthesenon-negativedataoftenexhibit

sub-stantialpositiveskewness,“heavy”uppertailandamassatzero

fornon-users, asinourstudy,forthosepatientswhowerenot

hospitalizedinthe31–365observationperiod[50–52].

Theskewnessofthecostdistributionswasapproachedusing

GeneralizedLinearModels(GLMs).Inparticular,toestimate

hospi-talizationspendingatthepatient’sindexadmission,at30days,and

at1yearfollowup;threedifferentGMLsweretested,specifying

severalfamilies(Gamma,Poisson,InverseGaussian)andalinklog

function.ThemodifiedParktest[53]andHosmer-Lemeshowtest

[54]wereappliedtochoosethespecificationwiththebettermodel

fitting. For the three dependent variables here considered, the

testsindicatedthattheGamma-Loglinkmodelwasadequate

com-paredtoothertypesofdistributions.Differently,atwo-partmodel

[50,55,56]wasusedtoestimatehospitalization costsat31–365

follow-upperiod(conditionalonsurvivingthefirst30days).This

allowstocontrolforthezero-inflationaffectingthehospitalization

costsinthisobservationperiod.Two-partmodeliscomposedby

tworelatedequation:inthefirstpartofthemodel(Eq.(2)inthis

paper)theprobabilitytoobserveapatientintheperiod31–365

daysismodelledviaprobitregression.Inthesecondpartofthe

model(Eq.(3)inthispaper),thelevelofhospitalexpenditureforthe

patientshospitalizedintheperiod31–365daysismodelledusinga

GLMwithGamma-Loglinkspecification.Allconsideredmodelsare

adjustedforage,sex,ST-segmentAMIandselectedcomorbiditiesat

baselinewhichwereretrieved,foreachpatient,atboththeindex

andinallhospitalizationsoneyearpriortotheindex.Adummy

variableindicatingthepatient’sregionofresidence(1=Lombardy,

0=Tuscany)wasalsoincludedasacovariateinthemodels,inorder

tomeasurethedifferencesbetweenthetworegions.

Thiseconometricapproachcanbeformulatedasfollow:

Model1:Dependentvariables:costatIndex,0–30dayspost

AMI,andat1year

E(Cosi|X)=exp(X/!)

Wherei=1,....,naretheLombardyandTuscanypatients,Xisthe

matrixofthecovariatesand!isthevectorofthecoefficients.Using

similarnotation,Model2forthedependentvariableexpressing

costat31–365dayspostAMIcanbeformulatedasfollow:

E(CostiX) =Pr (Costi>0X) *E (Costi>0,X) (2)

Whichiscomposedby:

Pr (Costi>0X) = exp(Xϕ) 1+exp(Xϕ) (3) E(Costi>0,X) =exp

!

X#

"

(4)

Asanticipated,differentlyfromModel1,whenweestimatethe

costfor31–365days,weneedtocontrolfortheprobabilitytobe

aliveafter30days.Forthisreason,thetwo-partmodelapproachas

describedbyEq.(2)isadopted,whereEq.(3)estimatesthe

prob-abilitytobealiveat30daysandEq.(4)estimatestheexpenditure

adjustedfortheprobabilitytobealiveat30days.

DifferencesinadjustedcostsbetweenthetwoItalianregions

wereestimatedusingrecycledpredictions.Thismethodavoidsthe

problemofthecovariatesimbalanceaffectingnonlinear

retrans-formationsinGLM[56],andconsistsin1000bootstrapreplications

usedtoestimate95%-bootstrap-percentile-intervals[56,57]ofthe

differencebetweentheexpenditureinTuscanyandLombardy.

Moreover, although the study wasnot designed to test the

impactofspendingonhealthoutcomes,wecomparedmortality

ratesbetweenthetwo regionsafteradjustingfor age,sex,race,

ST-segmentAMI,andcomorbiditiesatbaselinebyusingalogistic

regression.Theavailabledatadidnotallowustoanalyse

possi-bledifferencesinnon-clinicaloutcomessuchaspatients’reported

outcomesorsatisfaction.

Finally,asensitiveanalysiswasperformedaimedatchecking

for potentialselection biasdue tothemainconfounders andto

potentialdifferencesincodingpracticesbetweenthetworegions,

we replicatedtheanalysisbyfirst matchingthepatientsofthe

tworegionsonage,sexandcomorbiditiesusingaCoarsenedExact

Matching(CEM)non-parametricapproach[32,58,59].Theglobal

balancebetweenthepatientsbelongingtothetworegionswas

(4)

Table2

SampleCharacteristicsCareProvidedtopatientsadmittedforAcuteMyocardialInfarction.

Patientscharacteristics Lombardy(N=30,225) Tuscany(N=13,187) P-value

Mean(SD) Mean(SD)

Age 70.325 (13.404) 71.940 (13.329) <0.001

Male 0.647 (0.478) 0.637 (0.4808) 0.068

Lipidmetabolismdisorder 0.093 (0.290) 0.212 (0.408) <0.001

Cancer 0.031 (0.174) 0.036 (0.185) 0.027

Diabetes 0.132 (0.338) 0.212 (0.408) <0.001

Hypertensivediseases 0.209 (0.406) 0.411 (0.4925) <0.001

Otherformsofischemicheartdiseases 0.248 (0.431) 0.350 (0.477) <0.001

PreviousHeartfailure 0.173 (0.3773) 0.268 (0.442) <0.001

Conductiondisordersandcardiacdysrhythmias 0.182 (0.3857) 0.209 (0.406)

Cerebrovasculardiseases 0.054 (0.225 0.073 (0.260) <0.001

Vasculardiseases 0.039 (0.192) 0.060 (0.237) <0.001

Chronicobstructivepulmonarydisease 0.040 (0.195) 0.066 (0.249) <0.001

Chronicnephropathies 0.070 (0.254) 0.116 (0.320) <0.001

N-STEMI 0.513 (0.499) 0.557 (0.496) <0.001

Treatmentsatindexadmission

PCI 0.624 (0.484) 0.594 (0.491) <0.001

CABG 0.019 (0.135) 0.009 (0.093) <0.001

Patientoutcomesa

30daymortality 0.077 (0.001) 0.075 (0.002) 0.753

1yearmortality 0.167 (0.001) 0.157 (0.002) 0.055

PatientspendinginEuros(D)b

Index 7,324 (4,336) 6,610 (3,204) <0.001

30day 9,033 (6.032) 8,037 (5,227) <0.001

31-365dayc 3,668 (7,236) 3,044 (6,537) <0.001

1year 12,419 (9,908) 10,854 (8,682) <0.001

aRepresentsrisk-adjustedpercentage(standarderror).

bSpendingisadjustedforregionaldifferencesinDRG-tariffsystems. c Conditionalonsurvivingthefirst30days.

4. Results

Weidentified13,187patientsinTuscanyand30,225in

Lom-bardy who were hospitalized for AMI in the years 2012 and

2013.AsshowninTable2,Tuscanpatientsweresignificantlyolder

andshowedmorecomorbiditiesonaveragethantheLombardy

patients(p<0.001).Theseresultscouldexplainthehigher

signifi-cantpercentageofNSTEMI(non-STsegmentelevationmyocardial

infarction)patientsinTuscanycomparedtoLombardy,with56%

and 51% respectively (p<0.001). Otherstudies have foundthat

patientshospitalizedforSTEMI(STsegmentelevationmyocardial

infarction)weremorelikelytobeyounger,male,andwereless

likelytohaveapriorhistoryofseveralcomorbidities[60].

Additionally, Lombardypatientsweremore likely toreceive

invasivetreatmentssuchasPCIorCoronaryArteryBypassGraft

(CABG) at theindex admission(p<0.001). Aftercontrolling for

patientcharacteristics,adjustedmortalityratesattheacutephase

(within30daysoftheAMI)wassimilarinthetworegions(7.7%

and7.5%inLombardyandTuscanyrespectively)whereas,inthe

longer-term(oneyear),themortalityofAMIpatientsinLombardy

wasaboutonepercentagepointshigherthaninTuscany(adjusted

1yearmortalityrates,16.7%inLombardyand15.7%inTuscany)

However,theadjustedratesatbothobservationperiodsdidnot

differsignificantlyacrossthetworegions.

Unadjusted mean hospital spending, standardized for the

regionaldifferencesintheDRGtariffsystems,weresignificantly

higherinLombardycomparedtoTuscanyacrossalltheobservation

periods.

Morespecifically,totalone-yearspendingperpatientwas14%

higherinLombardythanTuscany(p<0.001).Theregionalgapin

spending waslower in theacutephase of AMIwithLombardy

exceedingTuscanyby11%and12% (p<0.001) attheindexand

within30daysrespectively.Ontheotherhand,thelongerterm

post-admissionperiod hadthegreatestinterregionalgapinthe

spending.Thatis,between31and365days,spendingfor

hospi-talreadmissionwasonaverage20%higherinLombardycompared

withTuscany(p<0.001).Totalexpendituresinthispost-acutecare

phaseaccountedforrespectively27%and26%ofthetotal1year

spendinginLombardyandTuscany.

Atotalof41%oftheLombardypatientswerereadmittedatleast

onceinthe31–365daysaftertheindexadmissioncomparedwith

37%oftheTuscanypatients.Inbothregions,thehighestvolumes

ofhospitalizationswereforcardiovascularinterventions,although

therateofrehospitalizationforrevascularizations(eitherCABGor

PCI)washigherinLombardycomparedtoTuscany(Fig.1).Indeed,

almost9%and2%ofthereadmissionsinLombardywerefor

per-cutaneouscardiovascularprocedureswithadrug-elutingstentand

barestentrespectively,comparedto5%and1%inTuscany,whereas

1%ofthereadmissionswereforCABGinLombardycomparedto

0.5%inTuscany

Table3describestheregionaltrendsintheLengthofStay(LOS)

togetherwiththepercentageofhospitalizationwithLOS

exceed-inganestablishedthreshold(long-stayoutliers).TheaverageLOS

attheindexforLombardywastwodayslongerthaninTuscany,

whereasinthepost-acutecare(31–365dayspostadmission),the

averagelengthofstaywasabout10and7daysforLombardyand

Tuscany,respectively.BesideshavingonaveragelongerLOS

com-paredwithpatientsinTuscany(p<0.001),patientsinLombardy

werealsolikelytoexperiencegreaterlengthsofstaythantheDRG

specificLOSthresholdbothatindexandinthe1-yearfollow-up

(p<0.001).Indeed,theproportionsofhospitalizationsclassifiedas

long-stayoutliersinLombardywerealmosttwicethoseof

Tus-cany,thusleadingtohigherhospitalspendingforthesameDRGin

LombardycomparedtoTuscany.

Theresultspresentedabovewereconfirmedbyfindingsfrom

themultipleregressionofhospitalspendingforAMI(Fig.2),which

showedthatalsoafteradjustingforcomorbiditiesandfor

differ-encesinDRGtariffs,adjustedhospitalspendingwassignificantly

higherinLombardythanTuscanyacrossallobservationalperiods.

(5)

Fig.1. Re-hospitalizationinthe31–365daysfollowingtheindexadmissionperpatientwithAcuteMyocardialInfarction(AMI)forthemostcommonsurgicalinterventions.

Table3

Analysisofthelengthofstay.

Lombardy Tuscany P-value

Index

AverageLengthofStay(SD) 8.987 (6.979) 6.898 (5.239) <0.001

%hospitalizationoverDRGthreshold(SD) 20.206% (40.154) 9.559% (29.404)

Upto30daysaftertheindexadmission

AverageLengthofStay(SD) 10.356 (8.920) 7.471 (6.485) <0.001

%hospitalizationoverDRGthreshold(SD) 20.874% (40.640) 9.584% (29.437)

31to365daysaftertheindexadmission

AverageLengthofStay(SD) 10.477 (12.134) 7.961 (10.729) <0.001

%hospitalizationoverDRGthreshold(SD) 13.625% (34.306) 7.854% (26.903)

1yearaftertheindexadmission

AverageLengthofStay(SD) 10.396 (10.108) 7.629 (8.108) <0.001

%hospitalizationoverDRGthreshold(SD) 18.452% (38.791) 9.024% (28.653)

(6)

patienthospitalizedinLombardywasonaverage2081euroshigher

thanthatforAMIpatientshospitalizedinTuscany(p<0.001).On

theotherhand,themeandifferencesbetweenLombardyand

Tus-canywere774and1197eurosforthehospitalizationcostsatindex

admissionandinthefirst30days(p<0.001)respectively.

More-over,inthetwo-partmodel,comparedwithTuscany,Lombardy

incurred onaverage 941 eurosextra (p<0.001) in

hospitaliza-tionexpenditureinthelonger-term(31–365days)post-admission

period.

ResultsoftheCEManalysisreportedalowerpost-matchingL1

valuewhichdecreasesfrom0.51to0.28indicatingahigh-quality

match(astrongreductionintheunbalancingofthecovariates).

AveragehospitalspendingofthematchedsamplesofAMIpatients

ofLombardyand Tuscanywerefoundtobesignificantly

differ-ent.Thismeansthatevenafterremovingpotentialselectionbias

duetodifferentclinicalanddemographiccharacteristicsofthetwo

AMIcohorts,hospitalspendingremainssignificantlyhigherin

Lom-bardyregioncomparedtoTuscanyacrossallthestudyobservation

periods(p<0.001).

Aftermatchingthetwocohorts,significantregionaldifferences

werealsoobservedforbothLOSandvolumeofrevascularizations

(eitherCABGorPCI)inthe31–365observation,whichremained

higherforLombardypatients(p<0.001)comparedtoTuscanyones.

Onthecontrary,wedidnotobserveanydifferenceintermsof

mor-talitybetweenTuscanyandLombardyinalltheobservationperiods

(p>0.10)

5. Discussion

Theliteratureongeographicvariationhaswidelyprovedthat

thereareavarietyoffactorsthatcontributetoexplainregional

variationsinhealthcarespending andutilization.Someofthese

factorssuchasthedifferentpatients’needsandpreferencesare

“warranted”,whereas,theultimatechallengeforpolicymakersis

reducingregionalsvariationsdueto“unwarranted”factorswhich

ultimatelyreflectsysteminefficiencies.

Inthisstudy,weanalysetheextentofregionalvariationin

hos-pitalspendingforAMIpatientsacrosstwoItalianregions,Tuscany

andLombardy,bothwithhighqualityhealthcaresystemsbutwith

differentregionalgovernancemodelsforfinancinganddelivering

healthcare.

Inlinewithpreviousstudiesreportingthatdifferencesinprices

andpatienthealthstatusaccountforonlyapartofthevariationin

spending[6,17,61],wefoundthat,comparedwithTuscany,

Lom-bardypresented significantly higheradjusted spending for AMI

patientsatboththeacutephase(within30daysoftheAMI

hos-pitalization)andinthelonger-term(31–365days)post-admission

periods.Morespecifically,afteradjustingfordifferencesinpatients’

case-mixand regionalDRG tariffs,the averageannual hospital

costperAMIpatientstillsignificantlydifferedbetweenthetwo

regionsanditwasonaverage2081euroshigherinLombardy

com-paredtoTuscany.Ontheotherhand,aftercontrollingforpatients’

characteristics, themortality rates at acute (within 30 days of

theAMI)andlonger-termpostadmissionperiod(1year)ofthe

AMIdidnotsignificantlydifferbetweenthetworegions.Results

werealsoreinforcedbytheCEManalysiswhichshowsthatthein

matchedsamplesLombardyreportedsignificantlyhigherAMI

hos-pitalspendingcomparedtoTuscanywhereasthetworegionsdid

notsignificantlydifferintermsofAMImortalityacrossthestudy

periodsBeyondtheseobserveddifferencesinregionalspending,

thestudyattemptstocontributetothediscussiononthe

poten-tialdriversatsystemlevelofvariationsinhospitalspendingacross

regionalhealthcaresystemswithcomparablehealthoutcomesand

populations.

WefoundthattheaverageLOSwashigherinLombardy

com-paredtoTuscany,withapercentagedifferencebetweenLombardy

andTuscanyrangingbetween30%attheindexat36%at1year

follow-up.Moreover,theproportionofhospitalizationswithlonger

thanastatedLOSoutlierthresholdwasalmostdoubleinLombardy

withrespecttoTuscanyacrossallthestudyperiodsandthiswas

truealsointhematchedcohorts.

Lombardy’shigherpercentageoflong-stayoutliers,especially

in the post-acute phase, could, for instance, suggest that this

regionalhealthcaresystemmightlackeffectivetransitional

pro-gramsbetweentheacutehospitalsectorandcommunityservices

fortheAMIpatients,especiallyforthosewhoaremoreinneedof

coordinateddischargeandongoingsupport[62].

Furthermore,between31and365days,AMIpatientsin

Lom-bardyweremorelikelytobereadmittedcomparedtoTuscany.In

particular,higherratesofrepeatedPCIwereobservedinthe31–365

daysfortheLombardypatientswithrespecttotheTuscanyones

inboththematchedandnotmatchedcohorts.Intheliterature,

activity-relatedfundingwasfoundtoprovideincentivesforgreater

volumes[63,64]andthereforetopotentiallyleadtodifferentlocal

practicepatterns.Indeed,inthis context,wemighthypothesize

adifferentprofessionals’choiceonrevascularizationmodalityin

patientswithmulti-vesseldisease.PCIMulti-vesselcaninfactbe

performedeitheratthetimeoftheindexhospitalizationorat

sepa-ratesubsequenthospitalizations.Althoughtheidentificationofthe

optimaltimingofastagedprocedureinAMIpatientsstillrequired

furtherinvestigation,clearlythestrategyofproceduresperformed

inrepeatedhospitalizationsleadstoincreasedhospitalcostswith

respecttotreatothervesselsatonestage[65,66].

Variationsinproceduresratesandintheuseofresources(e.g.

differentLOSforsimilarpatients)especiallyinthepost-acutephase

mightbealsoexplainedbyregionaldifferencesinother

supply-sidefactorssuchasprovider’scapacity(e.g.hospitalandlong-term

carebedsperthousand,numberofcardiacfacilities)[67,3,68].As

anexample,cardiachospitalbedsin2013were2.29per100,000

inhabitantsinLombardyregioncomparedwith1.53per100,000

inhabitantsinTuscany(Source:Ministryofhealth-http://www.

dati.salute.gov.it/dati/homeDataset.jsp).Theavailabledatadidnot

allowustoanalysedifferencesinout-of-hospitalresourcecapacity.

Indeed, these results seem to confirm that, even between

regionalhealthcaresystemsdominatedbyhighstandardsofcare,

there can exist both different type of organizational structures

withinandbetweencaresettingsanddifferentlevelsof

profes-sionals’discretionoverthecareprovidedforsimilarpatients.

Wethereforehypothesizethatsystem-levelfactors,suchasthe

differentreimbursementsystems,andthedifferentorganization

andlevelofintegrationbetweenacutehospitalprovidersand

com-munitycareservicesinthetworegions,mightcontributetoexplain

thesupply-sideofvariationinexpenditureand,moregenerally,the

valueformoneythatisproduced.

Targetpolicieswhichfavouroutcomegoalsandfacilitate

con-tinuityofcarebetweenhospitalandpost-hospitalizationsettings

canincentivizehospitalstowardsamoreefficientuseoftheirinput

resources (i.e.hospital beds), allowto efficiently reallocate the

resourceswhereservicesmayprovidemorevalueforpatientsand

toguaranteeinganappropriatesupporttopatientsfromonehealth

caresettingtoanother[69].

TheperformanceevaluationsystemadoptedinTuscany[40,70]

allowsphysicianstobemoreawareoftheimpactoftheirchoices

ontheuseofresourcesthankstotheanalysisofadministrative

datathroughthepatients’clinicalpathperspective.Additionally,

benchmarkingandpublicdisclosureofoutcomeresultsand the

participationofphysiciansinmeeting,stronglyenhancedbythe

regionalgovernment,aimedatidentifyingandsharingbest

prac-ticehelpingTuscanclinicianstouniformbehaviorsatregionallevel

puttingreputationtowork[71].

Asmatter of fact,in 2016 theLombardyRegion hasstarted

(7)

overcom-ingthequasimarketgovernancesysteminfavouroftheintegration

betweenhospital and primary care, reducing readmissionsand

increasingtheappropriateness.Moreover,Lombardydecidedtobe

partofanetworkof10ItalianRegionsthatadoptaunique

per-formanceevaluationsystem,basedontargetsetting,competitive

benchmarking,andpublicdisclosureofdata[75].Thisisaimedat

improvingqualitydeliveredandatcontainingtheexpenditure.

Thestudysuffersfromsomerelevantlimitationsmanyofwhich

related to the data and design of the study. First, as with all

observationaldata,weareunabletomakeinferencesabout

causa-tion,therefore,effectestimatesshouldbecautiouslyinterpreted.

Second,aswithotherstudiesusingadministrativedata[72,73],

informationwaslackingonpotentialconfoundingvariablessuch

asAMIseverity,lifestylefactors,treatmentadherence,and

proce-duralcharacteristics.Moreover,thetypeofdatadonotallowto

carefullyevaluatetheappropriatenessofstrategiesbothadopted

inthetworegionsfortheAMItreatmentbothattheindexandinthe

31–365hospitalizations.However,theuseofadministrativedata

hasbeenwidelyadoptedbyhealthcareagenciesandother

stake-holderstomeasurehospitalperformance.Thisisbecausesuchdata,

comparedtoclinicalregistries,areeasilyaccessible,relatively

inex-pensivetouse,andenableinformationtobecollectedontheentire

populationofconcern[74].

Othervariablesthat areimportanttothecomparisonsbeing

mademighthavebeingomittedorunmeasuredinthisstudysuchas

informationonAMIpatientsthatmaydiebeforereachingthe

hos-pital,whichcouldprovideindicationonwhetherhospitalpatient

populationsdifferacrossthetworegions.

Finally,atthisstageoftheanalysis,wefocusedourstudyonthe

treatmentofAMIonlyandwerecognizedthatfindingsmightnot

extendtotherestofhealthcare.Also,wewereonlyableto

con-siderhospitalizationspendingandcouldnotincludenon-clinical

outcomes.

Despitetheselimitations,ourstudyhasseveralstrengths.Tothe

bestofourknowledge,thisisthefirststudythathasanalysed

geo-graphicaldifferencesinhealthcarespendingbetweentworegional

healthcaresystemsinItaly,inalongertimeframethanthe

arbi-trary30daysoftheacutecarephase.Inaddition,comparedtothe

otherstudies,theopportunitytocomparetheregionalhealthcare

systemsinItalyallowsustoanalysegeographicvariationbetween

tworegionsthataresimilarintermsofbothsocio-economicfigures

andcitizens’standardoflivingbutdifferintermsofthegovernance

andfundingmodelsoftheirhealthcaresystems.Thismight

facili-tatetheidentificationofsupply-sidefactorsthatcouldpotentially

explainsysteminefficiencies.

6. Conclusions

Health systems arelooking forways toshifttovalue-based

healthcare.Ourstudysuggeststheimportanceofconsideringthe

impactofthegovernancesystemasoneofthepossible

determi-nantsofgeographicvariationwhencomparingdifferentregional

healthcaresystems.Althoughthedifferentregionalorganizational

modelsmaynotleadalonetoreductionsinunwarrantedvariations

inspending,thechoicetointroducequasi-marketmechanismsto

promote bothefficiencyand efficacyseemstobelessfavorable

thentheintroductionofgovernancebasedonplanning,target

set-tingandcompetitivebenchmarkingonqualityofcare,moreoverif

partneredwithastrongintegrationbetweenacuteandpost-acute

services.

Conflictofinterest

Theauthorsdonothaveanyconflictsofinteresttodeclare

Acknowledgements

Wewouldliketothanktheregionalandlocalrepresentatives

ofbothregionsandalltheresearchersandcolleagues(inparticular

fromtheMeS-LabandtheDartmouthInstitute)fortheirvaluable

support.WewouldalsoliketothanktheScientificCommittee,Prof.

VeronicaGrembiandalltheparticipantsofthe5thHealth

Econo-metricsWorkshop-Bari(Italy)andTheWennbergInternational

Collaborativecommunityfortheircommentsandsuggestions.

References

[1]Paul-ShaheenP,ClarkJD,WilliamsD.Smallareaanalysis:areviewand analy-sisofthenorthAmericanliterature.JournalofHealthPolitics,PolicyandLaw 1987;12(4):741–809.

[2]Wennberg JE. Time to tackle unwarranted variations in practice. BMJ 2011;342:d1513.

[3]FisherES,WennbergDE,StukelTA,GottliebDJ,LucasFL,PinderEL.The impli-cationsofregionalvariationsinmedicarespending.Part1:thecontent,quality, andaccessibilityofcare.AnnalsofInternalMedicine2003;138(4):273–87. [4]FisherES,WennbergDE,StukelTA,GottliebDJ,LucasFL,PinderEL.The

impli-cationsofregionalvariationsinmedicarespending.Part2:healthoutcomes andsatisfactionwithcare.AnnalsofInternalMedicine2003;138(4):288–98. [5]SkinnerJ,FisherE.Reflectionsongeographicvariationsinushealthcare.

Dart-mouthInstituteforHealthPolicyandClinicalPractice2013;12(May). [6]WennbergJE,FisherES,SkinnerJS.Geographyandthedebateovermedicare

reform.HealthAffairs2002:W96–114.Jul-Dec;SupplWebExclusives. [7]MedicarePaymentAdvisoryCommission(MedPAC),FebruaryRegional

varia-tioninMedicarePartA,PartB,andPartDspendingandserviceuse;2017. [8]InstituteofMedicine.Interimreportofthecommitteeongeographic

varia-tioninhealthcarespendingandpromotionofhigh-valuecare:preliminary committeeobservations.Washington,DC:TheNationalAcademiesPress;2013. [9]CoralloAN,CroxfordR,GoodmanDC,BryanEL,SrivastavaD,StukelTA.A sys-tematicreviewofmedicalpracticevariationinOECDcountries.HealthPolicy 2014;114(1):5–14.

[10]McPhersonK,GonG,ScottM,OECDHealthWorkingPapersNo.61International variationsinaselectednumberofsurgicalprocedures.Paris:OECDPublishing; 2013.

[11]OECD.Geographicvariationsinhealthcare:whatdoweknowandwhatcan Bedonetoimprovehealthsystemperformance?OECDPublishing;2014. [12]Wennberg International Consortium (WIC) (2016). http://

wennbergcollaborative.org/index.php.

[13]HeijinkRichard,EngelfrietPeter,RehnbergClas,KittelsenSverre,Hakkinen Unto.Awindowongeographicvariationinhealthcare:insightsfrom Euro-HOPE.HealthEconomics2015;24(Suppl.2):164–77,http://dx.doi.org/10.1002/ hec.3287.

[14]Medicare Payment Advisory Commission (MedPAC), January Report to congress:regionalvariationinmedicareservicesuse;2011.

[15]CutlerD,SkinnerJ,SternAD,WennbergD.Physicianbeliefsandpatient prefer-ences:anewlookatregionalvariationinhealthcarespending(No.w19320). NationalBureauofEconomicResearch;2013.

[16]ZuckermanS,WaidmannT,BerensonR, etal. Clarifyingsourcesof geo-graphicdifferencesinMedicarespending.NewEnglandJournalofMedicine 2010;363(July(1)):54–62.

[17]ReschovskyJD,HadleyJ,RomanoPS.Geographicvariationinfee-for-service medicarebeneficiaries’medicalcostsislargelyexplainedbydiseaseburden. MedCareResRev2013;70(5):542–63.

[18]YasaitisL,FisherES,SkinnerJS,ChandraA.Hospitalqualityandintensityof spending:isthereanassociation?HealthAffairs(Millwood)2009;28:w566–72. [19]SirovichBE,GottliebDJ,WelchHG,FisherES.Regionalvariationsinhealth careintensityandphysicianperceptionsofqualityofcare.AnnalsofInternal Medicine2006;144:641–9.

[20]BaickerK,ChandraA.Medicarespending,thephysicianworkforce,and ben-eficiaries’qualityofcare.HealthAffairsWebExclusives2004(January–June): W4-184–W4-197.

[21]OngMK,MangioneCM,RomanoPS,ZhouQ,AuerbachAD,ChunA,etal. Look-ingforward,lookingback:assessingvariationsinhospitalresourceuseand outcomesforelderlypatientswithheartfailure.Circulation:Cardiovascular QualityandOutcomes2009;2:548–57.

[22]BarnatoAE,ChangCCH,FarrellMH,LaveJR,RobertsMS,AngusDC.Issurvival betterathospitalswithhigher“end-of-life”treatmentintensity?MedicalCare 2010;48(2):125.

[23]RomleyJA,JenaAB,GoldmanDP.Hospitalspendingandinpatientmortality: evidencefromCalifornia:anobservationalstudy.AnnalsofInternalMedicine 2011;154:160–7.

[24]SilberJH,KaestnerR,Even-ShoshanO,WangY,BresslerLJ.Aggressive treat-mentstyleandsurgicaloutcomes.HealthServicesResearch2010;25:1872–92. [25]DoyleJrJJ,GravesJA,GruberJ,KleinerSA.Measuringreturnstohospital care:evidencefromambulancereferralpatterns.JournalofPoliticalEconomy 2015;123(1):170–214.

[26]GöpffarthD,KopetschT,SchmitzH.Determinantsofregionalvariationin healthexpendituresinGermany.HealthEconomics2016;25(7):801–15.

(8)

[27]SchreyöggJ,StargardtT,TiemannO.Costsandqualityofhospitalsindifferent healthcaresystems:amulti-levelapproachwithpropensityscorematching. HealthEconomics2011;20(1):85–100.Jan.

[28]GutackerN,BojkeC,DaidoneS,DevlinNJ,ParkinD,StreetA.Truly ineffi-cientorprovidingbetterqualityofcare?Analysingtherelationshipbetween risk-adjustedhospitalcostsandpatients’healthoutcomes.HealthEconomics 2013;22(Aug(8)):931–47.

[29]HäkkinenU,RosenqvistG,PeltolaaM,KapiainenS,RättöH,CotsF,etal. Qual-ity,cost,andtheirtrade-offintreatingAMIandStrokepatientsinEuropean hospitals.HealthPolicy2014.

[30]KittelsenSAC,AnthunKS,GoudeF,HuitfeldtIMS,H ¨akkinenU,KruseM,etal. CostsandqualityatthehospitallevelinNordiccountries.HealthEconomics 2015;24(Suppl.2):140–63.

[31]BrennaE.Quasi-marketandcost-containmentinBeveridgesystems:the Lom-bardymodelofItaly.HealthPolicy2011;103(2):209–18.

[32]BertaP,BossiM,VerzilloS.%Cem:asasmacrotoperformcoarsenedexact matching.JournalofStatisticalComputationandSimulation2017;87(2):1–12. [33]BertaP,SeghieriC,VittadiniG.Comparinghealthoutcomesamong hospi-tals:theexperienceoftheLombardyRegion.HealthCareManagementScience 2013;16(3):245–57.

[34]NutiS,VolaF,BoniniA,VainieriM.Makinggovernanceworkinthehealthcare sector:evidencefroma‘naturalexperiment’inItaly.HealthEconomics,Policy andLaw2016;11(01):17–38.

[35]Likosky DS, Zhou W,Malenka DJ, Borden WB, Nallamothu BK, Skinner JS. Growthin medicareexpenditures forpatients with acutemyocardial infarction: acomparisonof1998through1999 and2008.JAMAInternal Medicine 2013;173(22):2055–61,http://dx.doi.org/10.1001/jamainternmed. 2013.10789.Dec9–23.

[36]ChandraA.Economicsmeetsthegeographyofmedicine;2013. [37]BeveridgeW.Socialinsuranceandalliedservices.London:HMSO;1942. [38]FerréF,DeBelvisAG,ValerioL,LonghiS,LazzariA,FattoreG,etal.Italy:health

systemreview.HealthSystemsinTransition2014;16(4):1–168. [39]GrayM.Valuebasedhealthcare.BMJ2017;356:j437.

[40]NutiS,DeRosisS,BoncianiM,MuranteAM.Re-thinkinghealthcare perfor-manceevaluationsystemstowardsthepeople-centerednessapproach:their pathways,theirexperience,theirevaluation.HealthcarePapers2017. [41]PianoNazionaleEsiti(NationalOutcomeProgram)(2015).http://95.110.213.

190/PNEed15/index.php.

[42]Anessi-PessinaE,Cantu `E,JommiC.Phasingoutmarketmechanismsinthe italiannationalhealthservice.PublicMoney&Management2004:309–16. [43]BertaP,MartiniG,MosconeF,VittadiniG.Theassociationbetweenasymmetric

information,hospitalcompetitionandqualityofhealthcare:evidencefrom Italy.JournaloftheRoyalStatisticalSociety:SeriesA(StatisticsinSociety) 2016;179(4):907–26.

[44]BertiS.Infarto,lareteIMAfa“90”,Sole24OreSanità;2014.p.14–20.Ottobre. [45]RegioneToscana,Availableonline:D.G.R.n.1380del27–12;2016http://www.

regione.toscana.it/bancadati/atti/?redirect=/bancadati/atti/DettaglioAttiG. xml%3fcodprat=2016DG00000001707.

[46]MarzegalliM,FontanaG,SesanaG,GriecoN,LombardiF,ElenaC,etal.Le retidell’emergenzainCardiologia:l’esperienzalombarda.GiornaleItalianodi Cardiologia2008;9(Suppl.1–10).

[47]RegioneLombardia,decreton.10446,15OttobreDirezioneSanitaria, Deter-minazioniinmeritoalla “reteperiltrattamento deipazienticoninfarto miocardicocontrattoSTelevato(STEMI)”;2009.

[48]KrumholzHM,NormandS,KeenanP,etal.Hospital30-dayacutemyocardial infarctionreadmissionmeasure:methodology.ReportpreparedfortheCenters forMedicare&MedicaidServices;2008.

[49]KrumholzHM,LinZ,KeenanPS,ChenJ,RossJS,DryeEE,etal.Relationship between hospital readmission and mortality rates for patients hospital-ized withacutemyocardialinfarction,heartfailure,orpneumonia.JAMA 2013;309(6):587–93.

[50]Mullahy J.Much adoabouttwo: reconsideringretransformation andthe two-part model in health econometrics. Journal of Health Economics 1998;17(3):247–81.

[51]MullahyJ.Econometricmodelingofhealthcarecostsandexpenditures:a surveyofanalyticalissuesandrelatedpolicyconsiderations.MedicineCare 2009;47(7Supplement1):S104–8.

[52]ManningW.Dealingwithskeweddataoncostsandexpenditures.In:Theelgar companiontohealtheconomics.Cheltenham:Elgar;2006.

[53]ManningWG,MullahyJ.Estimatinglogmodels:totransformornotto trans-form?JournalofHealthEconomics2001;20(4):461–94.

[54]HosmerJR,LemeshowS.Appliedlogisticregression.JohnWiley&Sons;2004. [55]TianL,HuangJ.Atwo-partmodelforcensoredmedicalcostdata.Statisticsin

Medicine2007;26(23):4273–92.

[56]GlickHA,DoshiJA,SonnadSS,PolskyD.Economicevaluationinclinicaltrials. OUPOxford;2014.

[57]BasuA,PolskyD,ManningWG.Estimatingtreatmenteffectsonhealthcare costsunderexogeneity:isthereamagicbullet?HealthServicesandOutcomes ResearchMethodology2011;11(1-2):1–26.

[58]IacusSM,KingG,PorroG.Multivariatematchingmethodsthatare mono-tonicimbalancebounding.JournaloftheAmericanStatisticalAssociation 2011;106(493):345–61.

[59]IacusSM,KingG,PorroG.Causalinferencewithoutbalancechecking: coars-enedexactmatching.PoliticalAnalysis2012;20(1):1–24.

[60]McManusDD,GoreJ,YarzebskiJ,etal.Recenttrendsintheincidence, treat-ment,andoutcomesofpatientswithstemiandnstemi.TheAmericanJournal ofMedicine2011;124(1):40–7.

[61]Gottlieb DJ, Zhou W, Song Y, Andrews KG, Skinner JS, Sutherland JM. Prices don’t drive regional medicarespending variations. Health Affairs 2010;29(3):10–377.

[62]CostaAP,PossJW,PeirceT,HirdesJP.Acutecareinpatientswithlong-term delayed-discharge:evidencefromaCanadianhealthregion.BMCHealth Ser-vicesResearch2012;12(172).

[63]WeeksWB,ParaponarisA,VentelouB.Geographicvariationinratesofcommon surgicalproceduresinFrancein2008–2010,andcomparisontotheUSand Britain.HealthPolicy2014;118(2):215–21.

[64]Emanuel EJ, Fuchs VR. The perfect storm of overutilization. JAMA 2008;299(23):2789–91.

[65]AmericanCollegeofCardiology,availableonlineatAmericancollegeof cardiol-ogythemanagementofMVDinSTEMI:thescienceandartofdecision-making inSTEMI;2018https://www.acc.org/latest-in-cardiology/articles/2018/02/07/ 07/45/the-management-of-mvd-in-stemi.

[66]LiZ,ZhouY,XuQ,ChenX.Stagedversusone-timecompleterevascularization withpercutaneouscoronaryinterventioninSTEMIpatientswith multives-seldisease:asystematicreviewandmeta-analysis.PLoSOne2017;12(1), e0169406.

[67]CongressionalBudgetOffice.Geographicvariationinhealthcarespending,Vol. 2008.Washington,DC:CongressoftheUnitedStates,CBO;2008.

[68]WennbergDE,DickensJrJ,SouleDN,KellettJrM,MalenkaD,RobbJ,etal.The relationshipbetweenthesupplyofcardiaccatheterizationlaboratories, cardi-ologistsandtheuseofinvasivecardiacproceduresinnorthernNewEngand. JournalofHealthServicesResearch&Policy1997;2(2):75–80.

[69]NutiS,VainieriM,BoniniA.Disinvestmentforreallocation:aprocesstoidentify priorityinhealthcare.HealthPolicy2010;95:137–43.

[70]NutiS,NotoG,VolaF,VainieriM,ManagementDecisionLet’splaythepatients’ music:anewgenerationofperformancemeasurementsystemsinhealthcare; 2018.

[71]BevanG,EvansA,NutiS.Reputationscount:whybenchmarkingperformance isimprovinghealthcareacrosstheworld.HealthEconomics,PolicyandLaw 2018.

[72]KhawajaFJ,ShahND,LennonRJ,SlusserJP,AlkatibAA,RihalCS,etal. Fac-torsassociatedwith30-dayread-missionratesafterpercutaneouscoronary intervention.ArchivesofInternalMedicine2012;172(2):112–7.

[73]LindenauerPK,LaguT,RothbergMB,AvruninJ,PekowPS,WangY,etal.Income inequalityand30dayoutcomesafteracutemyocardialinfarction,heartfailure, andpneumonia:retrospectivecohortstudy.BMJ2013;346:f521.

[74]AustinPC,TuJV.Comparingclinicaldatawithadministrativedataforproducing acutemyocardialinfarctionreportcards.JournaloftheRoyalStatisticalSociety 2006;169(1):115–26.

[75]NutiS,BiniB,RuggieriTG,PiaggesiA,RicciL.Bridgingthegapbetween the-oryandpracticeinintegratedcare:thecaseofthediabeticfootpathwayin Tuscany.InternationalJournalofIntegratedCare2016;16(2):1–14.

Riferimenti

Documenti correlati

The thickness of the depleted layer depends on glass composition [10] and differs in the here reproduced samples: V3 shows low durability and the alteration extends from ~ 121 μm to

Background and Purpose The aim of this study was to assess the prevalence of extracranial carotid artery atherosclerosis and its relation to principal cardiovascular risk factors

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease:

Mandatory inputs to run the model are: meteorological data, soil characteristics, crop growth data (i.e. plants density and crop growing period) and management (such as

Virulence and resistance genes were unevenly distributed across different clones and infection types, with highly resistant and lowly virulent clones showing strong association

In particular, the LSPR can be tailored to a particular wavelength: there is a linear relationship between the absorption maximum of the LSPR band and the mean aspect ratio

The Bio-RA study is a sub-study of the Endothelial Dysfunction Evaluation for Coronary Heart Disease Risk Estimation in Rheumatoid Arthritis study (EDRA study. Inclusion criteria

biettivo è dotare la Città Metropolitana di un’infrastruttura verde, in cui le opere di difesa idraulica siano incorporate nel di- segno di un sistema continuo di spazi pub-